Sign in
8-K

Current Report

Kiniksa Pharmaceuticals International, plc Filed Acc 0001104659-25-016725

Agreement ended · Results of operations · Exit or restructuring costs

  • Item 1.02 Termination of a material definitive agreement
  • Item 2.02 Results of operations and financial condition
  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading tm257489d1_8k.htm…